Intellia Therapeutics, Inc. (NTLA)
11.21
+0.05
(+0.45%)
USD |
NASDAQ |
Oct 23, 16:00
11.15
-0.06
(-0.54%)
After-Hours: 20:00
Intellia Therapeutics Price to Book Value : 2.157 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.157 |
| October 22, 2026 | 2.147 |
| October 21, 2026 | 2.242 |
| October 20, 2026 | 2.278 |
| October 19, 2026 | 2.228 |
| October 16, 2026 | 2.197 |
| October 15, 2026 | 2.182 |
| October 14, 2026 | 2.199 |
| October 13, 2026 | 2.292 |
| October 12, 2026 | 2.420 |
| October 09, 2026 | 2.515 |
| October 08, 2026 | 2.424 |
| October 07, 2026 | 2.253 |
| October 06, 2026 | 2.380 |
| October 05, 2026 | 2.453 |
| October 02, 2026 | 2.359 |
| October 01, 2026 | 2.332 |
| September 30, 2026 | 2.320 |
| September 29, 2026 | 2.315 |
| September 28, 2026 | 2.197 |
| September 25, 2026 | 2.261 |
| September 24, 2026 | 2.340 |
| September 23, 2026 | 2.372 |
| September 22, 2026 | 2.442 |
| September 21, 2026 | 2.351 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.336 |
| September 17, 2026 | 2.359 |
| September 16, 2026 | 2.211 |
| September 15, 2026 | 2.186 |
| September 14, 2026 | 2.284 |
| September 11, 2026 | 2.259 |
| September 10, 2026 | 2.296 |
| September 09, 2026 | 2.349 |
| September 08, 2026 | 2.451 |
| September 04, 2026 | 2.451 |
| September 03, 2026 | 2.440 |
| September 02, 2026 | 2.455 |
| September 01, 2026 | 2.441 |
| August 31, 2026 | 2.449 |
| August 28, 2026 | 2.476 |
| August 27, 2026 | 2.522 |
| August 26, 2026 | 2.538 |
| August 25, 2026 | 2.600 |
| August 24, 2026 | 2.417 |
| August 21, 2026 | 2.471 |
| August 20, 2026 | 2.394 |
| August 19, 2026 | 2.555 |
| August 18, 2026 | 2.232 |
| August 17, 2026 | 2.326 |
| August 14, 2026 | 2.292 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Twist Bioscience Corp. | 19.67 |
| Beam Therapeutics, Inc. | 2.327 |
| Prime Medicine, Inc. | 16.66 |
| 10X Genomics, Inc. | 11.29 |
| Moderna, Inc. | 11.81 |
Price to Book Value Related Metrics
| PS Ratio | 22.52 |
| Price | 11.21 |
| Earnings Yield | -29.95% |
| Market Cap | 1.570B |